Oral MS drug Gilenya has yet to show ‘full potential'

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Oral MS drug Gilenya has yet to show ‘full potential'

Postby MSUK » Thu Apr 28, 2011 12:50 am


Novartis's multiple sclerosis pill Gilenya, which faces a threat from a rival product under development by Biogen Idec Inc, has yet to show its full potential, the Swiss drugmaker’s head of development said.

Gilenya, approved by U.S. regulators last year as the first pill against relapsing forms of multiple sclerosis, may also work in patients with a more severe form of the disease called primary progressive, Novartis’s Trevor Mundel said yesterday in a telephone interview. “We haven’t seen the full potential with Gilenya,” according to Mundel.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Return to Gilenya


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service